Lifeward Past Earnings Performance
Past criteria checks 0/6
Lifeward's earnings have been declining at an average annual rate of -11.5%, while the Medical Equipment industry saw earnings growing at 11.7% annually. Revenues have been growing at an average rate of 36.6% per year.
Key information
-11.5%
Earnings growth rate
54.0%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | 36.6% |
| Return on equity | -57.0% |
| Net Margin | -77.2% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Not Many Are Piling Into Lifeward Ltd. (NASDAQ:LFWD) Stock Yet As It Plummets 25%
Oct 30
Here's Why Lifeward (NASDAQ:LFWD) Must Use Its Cash Wisely
Oct 15ReWalk Robotics Ltd. (NASDAQ:LFWD) Soars 26% But It's A Story Of Risk Vs Reward
Aug 01Is ReWalk Robotics (NASDAQ:LFWD) In A Good Position To Deliver On Growth Plans?
May 30Investors Give ReWalk Robotics Ltd. (NASDAQ:LFWD) Shares A 28% Hiding
Mar 14We Think ReWalk Robotics (NASDAQ:RWLK) Needs To Drive Business Growth Carefully
Jan 09Shareholders May Be A Bit More Conservative With ReWalk Robotics Ltd.'s (NASDAQ:RWLK) CEO Compensation For Now
Sep 06Is ReWalk Robotics (NASDAQ:RWLK) In A Good Position To Deliver On Growth Plans?
Jul 04Is ReWalk Robotics (NASDAQ:RWLK) In A Good Position To Invest In Growth?
Mar 07Here's Why We're Not Too Worried About ReWalk Robotics' (NASDAQ:RWLK) Cash Burn Situation
Oct 04ReWalk Robotics gets a new CFO
Sep 08ReWalK Q2 2022 Earnings Preview
Aug 08ReWalk Robotics receives Israeli court approval for $8M stock buyback
Jul 21ReWalk Robotics (NASDAQ:RWLK) Is In A Good Position To Deliver On Growth Plans
May 11ReWalk Robotics: Catalysts On The Horizon
Mar 09Here's Why We're Not Too Worried About ReWalk Robotics' (NASDAQ:RWLK) Cash Burn Situation
Jan 24ReWalk Robotics: Getting All Non-Cash Assets For Free
Nov 24We're Hopeful That ReWalk Robotics (NASDAQ:RWLK) Will Use Its Cash Wisely
Jun 22ReWalk Robotics: Plenty Of Runway To Re-Establish Growth
Jun 15Revenue & Expenses Breakdown
How Lifeward makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 25 | -19 | 22 | 5 |
| 30 Jun 24 | 23 | -24 | 25 | 5 |
| 31 Mar 24 | 18 | -24 | 24 | 5 |
| 31 Dec 23 | 14 | -22 | 21 | 4 |
| 30 Sep 23 | 9 | -22 | 21 | 4 |
| 30 Jun 23 | 6 | -20 | 18 | 4 |
| 31 Mar 23 | 6 | -20 | 18 | 4 |
| 31 Dec 22 | 6 | -20 | 17 | 4 |
| 30 Sep 22 | 5 | -18 | 16 | 4 |
| 30 Jun 22 | 6 | -15 | 14 | 3 |
| 31 Mar 22 | 6 | -14 | 13 | 3 |
| 31 Dec 21 | 6 | -13 | 13 | 3 |
| 30 Sep 21 | 6 | -12 | 12 | 3 |
| 30 Jun 21 | 5 | -12 | 11 | 3 |
| 31 Mar 21 | 5 | -12 | 11 | 3 |
| 31 Dec 20 | 4 | -13 | 11 | 3 |
| 30 Sep 20 | 4 | -14 | 11 | 4 |
| 30 Jun 20 | 5 | -14 | 11 | 4 |
| 31 Mar 20 | 4 | -15 | 11 | 5 |
| 31 Dec 19 | 5 | -16 | 11 | 5 |
| 30 Sep 19 | 5 | -17 | 11 | 6 |
| 30 Jun 19 | 6 | -18 | 12 | 7 |
| 31 Mar 19 | 7 | -19 | 13 | 7 |
| 31 Dec 18 | 7 | -22 | 15 | 7 |
| 30 Sep 18 | 6 | -23 | 16 | 7 |
| 30 Jun 18 | 7 | -24 | 18 | 7 |
| 31 Mar 18 | 7 | -25 | 18 | 7 |
| 31 Dec 17 | 8 | -25 | 19 | 6 |
| 30 Sep 17 | 8 | -27 | 20 | 7 |
| 30 Jun 17 | 7 | -29 | 21 | 6 |
| 31 Mar 17 | 6 | -32 | 22 | 8 |
| 31 Dec 16 | 6 | -33 | 22 | 8 |
| 30 Sep 16 | 6 | -31 | 22 | 7 |
| 30 Jun 16 | 5 | -30 | 22 | 8 |
| 31 Mar 16 | 5 | -27 | 21 | 6 |
| 31 Dec 15 | 4 | -25 | 19 | 6 |
| 30 Sep 15 | 4 | -23 | 17 | 5 |
| 30 Jun 15 | 4 | -24 | 15 | 9 |
| 31 Mar 15 | 4 | -24 | 13 | 9 |
| 31 Dec 14 | 4 | -24 | 11 | 9 |
| 30 Sep 14 | 3 | -21 | 9 | 8 |
| 30 Jun 14 | 2 | -19 | 8 | 4 |
| 31 Mar 14 | 1 | -17 | 6 | 3 |
Quality Earnings: LFWD is currently unprofitable.
Growing Profit Margin: LFWD is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: LFWD is unprofitable, and losses have increased over the past 5 years at a rate of 11.5% per year.
Accelerating Growth: Unable to compare LFWD's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: LFWD is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (15%).
Return on Equity
High ROE: LFWD has a negative Return on Equity (-56.95%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/20 23:14 |
| End of Day Share Price | 2025/01/17 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Lifeward Ltd. is covered by 7 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Matthew Taylor | Barclays |
| William Plovanic | Canaccord Genuity |
| Swayampakula Ramakanth | H.C. Wainwright & Co. |